Aysen Yilmaz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aysen Yilmaz has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
D. Ülkü
Hacettepe University, Department of Engineering Physics, Beytepe 06800, Ankara, Turkey
2 shared publications- Pinar Camurlu
Department of Chemistry Akdeniz University 07058 Antalya Turkey
2 shared publications D. Kįsakürek
Middle East Tehcnical University, Department of Chemistry, Ankara, 06531, Turkey
1 shared publicationD. Kısakürek
Middle East Technical University, Department of Chemistry, Ankara, 06531, Turkey
1 shared publicationDamla Çetin Altındal
Department of Bioengineering, Hacettepe University, Beytepe,Ankara 06800, Turkey
1 shared publication- Deniz Uner
Department of Chemical Engineering, Middle East Technical University, Ankara, Turkey
1 shared publication
Latest Publications
- Open Access
- 10 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (37) , 42589-42598
Structural, Optical, and Neutron Sensitivity Properties of Yb3+/Tb3+ Codoped Alkaline Earth Tetraborates
This study explores the synthesis, structural properties, and multifunctional potential of Yb3+/Tb3+ codoped alkaline earth tetraborates (CaB4O7, MgB4O7, and SrB4O7) synthesized via solid-state (SS), solution combustion (SC), and combustion (C) methods. The multifunctional potential of the synthesized materials arises from their unique combination of properties in one material. The first property is related to their high boron content and thus to their high neutron capture cross section, providing effective functionality for boron neutron capture therapy (BNCT) and shielding. This enables the particles to be selective tumor cell destruction agents under neutron irradiation. The second property is their strong upconversion luminescence that allows for near-infrared light-triggered photodynamic therapy. This offers deep-tissue treatment capability along with BCNT. The third property is their excellent photochemical stability and low biotoxicity. This combination of therapeutic modalities within a single platform holds promise for synergistic and minimally invasive cancer treatment strategies, along with imaging capabilities and drug delivery. X-ray diffraction analysis confirmed the phase purity and crystal structures of CaB4O7 (CBO), MgB4O7 (MBO), and SrB4O7 (SBO). CBO crystallizes in a monoclinic structure with a P21/n(14) space group, while both MBO and SBO adopt orthorhombic structures with Pcba and Pnm21 space groups, respectively. Scanning electron microscopy revealed particle sizes ranging from 100 to 200 nm, with more uniform and smaller particles achieved by SC. Strong upconversion luminescence, driven by cooperative energy transfer between Yb3+ and Tb3+ ions, was observed in all materials, particularly in CBO and MBO codoped with 5% Yb3+ and 5% Tb3+. The quantum yields (QY) for CBO and MBO reached approximately 0.35. Furthermore, neutron sensitivity was significantly enhanced with 10B isotope enrichment, making these materials promising candidates for BNCT and neutron shielding applications. Cytotoxicity tests confirmed the biocompatibility of the materials, especially for CBO and MBO, which have maintained high cell viability.
- 10 September 2025
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 10 (37) , 42589-42598
Open AccessStructural, Optical, and Neutron Sensitivity Properties of Yb3+/Tb3+ Codoped Alkaline Earth Tetraborates
This study explores the synthesis, structural properties, and multifunctional potential of Yb3+/Tb3+ codoped alkaline earth tetraborates (CaB4O7, MgB4O7, and SrB4O7) synthesized via solid-state (SS), solution combustion (SC), and combustion (C) methods. The multifunctional potential of the synthesized materials arises from their unique combination of properties in one material. The first property is related to their high boron content and thus to their high neutron capture cross section, providing effective functionality for boron neutron capture therapy (BNCT) and shielding. This enables the particles to be selective tumor cell destruction agents under neutron irradiation. The second property is their strong upconversion luminescence that allows for near-infrared light-triggered photodynamic therapy. This offers deep-tissue treatment capability along with BCNT. The third property is their excellent photochemical stability and low biotoxicity. This combination of therapeutic modalities within a single platform holds promise for synergistic and minimally invasive cancer treatment strategies, along with imaging capabilities and drug delivery. X-ray diffraction analysis confirmed the phase purity and crystal structures of CaB4O7 (CBO), MgB4O7 (MBO), and SrB4O7 (SBO). CBO crystallizes in a monoclinic structure with a P21/n(14) space group, while both MBO and SBO adopt orthorhombic structures with Pcba and Pnm21 space groups, respectively. Scanning electron microscopy revealed particle sizes ranging from 100 to 200 nm, with more uniform and smaller particles achieved by SC. Strong upconversion luminescence, driven by cooperative energy transfer between Yb3+ and Tb3+ ions, was observed in all materials, particularly in CBO and MBO codoped with 5% Yb3+ and 5% Tb3+. The quantum yields (QY) for CBO and MBO reached approximately 0.35. Furthermore, neutron sensitivity was significantly enhanced with 10B isotope enrichment, making these materials promising candidates for BNCT and neutron shielding applications. Cytotoxicity tests confirmed the biocompatibility of the materials, especially for CBO and MBO, which have maintained high cell viability.
- 28 May 2008
- Published by Springer Nature in Topics in Catalysis
- Vol. 49 (3-4) , 204-208
Synthesis and NMR Characterization of Titanium and Zirconium Oxides Incorporated in SBA-15
- 28 May 2008
- Published by Springer Nature in Topics in Catalysis
- Vol. 49 (3-4) , 204-208
Synthesis and NMR Characterization of Titanium and Zirconium Oxides Incorporated in SBA-15
- 23 June 2007
- Published by Springer Nature in Journal of Materials Science
- Vol. 42 (20) , 8501-8508
Investigation of thermoluminescence properties of metal oxide doped lithium triborate
- 23 June 2007
- Published by Springer Nature in Journal of Materials Science
- Vol. 42 (20) , 8501-8508
Investigation of thermoluminescence properties of metal oxide doped lithium triborate
- 14 April 2007
- Published by Springer Nature in Journal of Materials Science
- Vol. 42 (15) , 6453-6463
Investigation of solid solution of ZrP2O7–Sr2P2O7
- 14 April 2007
- Published by Springer Nature in Journal of Materials Science
- Vol. 42 (15) , 6453-6463
Investigation of solid solution of ZrP2O7–Sr2P2O7
- 11 July 2006
- Published by Wiley in Crystal Research and Technology
- Vol. 41 (8) , 829-835
Synthesis, crystal structure and spectral analysis of diaquatetrakis(N‐methylimidazole)Ni(II)(2,4,6‐tribromophenol)
- 11 July 2006
- Published by Wiley in Crystal Research and Technology
- Vol. 41 (8) , 829-835
Synthesis, crystal structure and spectral analysis of diaquatetrakis(N‐methylimidazole)Ni(II)(2,4,6‐tribromophenol)
- 18 April 2005
- Published by Wiley in Crystal Research and Technology
- Vol. 40 (6) , 579-585
New zeotype borophosphates with chiral tetrahedral topology: (H)0.5M1.25(H2O)1.5[BP2O8]·H2O (M = Co(II) and Mn(II))
- 18 April 2005
- Published by Wiley in Crystal Research and Technology
- Vol. 40 (6) , 579-585
New zeotype borophosphates with chiral tetrahedral topology: (H)0.5M1.25(H2O)1.5[BP2O8]·H2O (M = Co(II) and Mn(II))
- 27 January 2005
- Published by Wiley in Crystal Research and Technology
- Vol. 40 (3) , 271-276
Synthesis, crystal structure and characterization of new transition metal compounds of bromophenols: Bis(2,4,6-tribromophenolato) di(N-methylimidazole)M(II) (M=Co, Cu)
- 27 January 2005
- Published by Wiley in Crystal Research and Technology
- Vol. 40 (3) , 271-276
Synthesis, crystal structure and characterization of new transition metal compounds of bromophenols: Bis(2,4,6-tribromophenolato) di(N-methylimidazole)M(II) (M=Co, Cu)